Introduction Although many clinical trials have demonstrated that anticoagulant therapy substantially reduces the risk of ischemic stroke in patients with atrial fibrillation (AF), some physicians are reluctant to use anticoagulants. We investigated attitudes of physicians in Japan toward anticoagulant therapy in chronic AF patients.
Introduction
Chronic atrial fibrillation (AF) is a common arrhythmia and increases in prevalence from approximately 2% in the population aged 60 to 69 years to 7% in 70 to 79 years (1) . AF is an important risk factor for ischemic stroke and has been reported to increase its risk about 5-fold (1, 2) . Several randomized clinical trials (RCTs) have shown that anticoagulant therapy decreases the incidence of thromboembolism by about 70% in patients with chronic AF (3) (4) (5) (6) (7) (8) . Consequently, most evidence-based guidelines recommend anticoagulant therapy for chronic AF patients requesting at the same time to be individualized according to each patient's risk for thromboembolism (9) (10) (11) .
However, anticoagulant therapy trends to be underutilized in chronic AF patients. In fact, only 21 to 60% of chronic AF patients were reportedly given anticoagulants in Western countries (12) . Physicians' perceived risk of anticoagulant therapy, i.e., increased frequency of haemorrhagic complications and cumbersome monitoring of prothrombin time among others, seems to be responsible for the reluctance of physicians to undergo the therapy. Several cross-sectional surveys on the management of chronic AF patients showed that physicians' perception of risk-benefit balance of anticoagulation affected their decision to anticoagulate chronic AF patients (12) . Patients'characteristics, such as age or comorbidity, and physicians' specialty also affected the decision making process.
In Japan, compared to western countries, anticoagulant therapy is far less likely to be given to chronic AF patients. The proportion of patients on anticoagulants has been reported only from 14 to 17% (13, 14) . The high incidence of hemorrhagic stroke (15) (16) (17) and low incidence of thromboembolic diseases (18) in the Japanese population might explain some of the low proportions of chronic AF patients on anticoagulants. Furthermore, a knowledge gap among primary care physicians regarding results of recent clinical trials, a lack of time to manage in an ideal way every patient at overcrowded outpatient clinics might be the reasons for such low anticoagulation rates in Japan.
The purpose of this study was to examine Japanese physicians' attitude toward anticoagulant therapy in chronic AF patients and to explore the reasons behind a low anticoagulation rate, if revealed, in Japan. We specifically examined what factors of physicians and patients would influence physicians' decision making in this regard.
Methods

Subjects and Methods
Self-administrated questionnaire was developed and distributed to participants of the 9th annual meeting of the Japanese Society of General Medicine in Tokyo in February 2001. Members of the Society were mostly primary care physicians, internists with subspecialties, and general internists who work at academic settings or teaching hospitals.
Measurements
In the questionnaire, we first asked about respondent's background characteristics: age, gender, number of years since graduation from medical school, specialization, and setting of their primary responsibility. Secondly, we asked questions on the following: their experiences of managing an acute thromboembolism in AF patients or bleeding complications due to anticoagulant therapy, and providing preventive therapy for thromboembolism due to AF; their accessibility to a cardiologist and/or a neurologist for consultation. Thirdly, we asked about their belief regarding degree of impact of clinical trial results on their own daily practice and their knowledge of and experience in evidence-based medicine (EBM).
Finally, we presented 8 vignettes of hypothetical patients with chronic nonvalvular AF (NVAF) (see Appendix). Each vignette included different sets of clinical characteristics of a hypothetical patient regarding age, presence or absence of risks for thromboembolism (a history of a transient ischemic attack 6 months ago) and bleeding complications (a history of a bleeding gastric ulcer 3 years ago). We asked the respondents to indicate which management they would choose for these hypothetical patients from among 6 options: "warfarin and aspirin", "warfarin", "aspirin", "warfarin or aspirin", "others" or "none of the above".
Statistical analysis
Based on the answers, we classified respondents into two groups: the one group who had a positive attitude and the other, a negative attitude toward anticoagulant therapy. The former group consisted of the respondents who chose "warfarin" or "warfarin and aspirin" for at least one of the 4 vignettes of hypothetical patients with no particular risk for bleeding complications. The rest of the respondents were considered as having a "negative attitude." Patients with no known risks for bleeding complications, as strongly recommended by authoritative practice guidelines (9) (10) (11) , should be on anticoagulant therapy regardless of other characteristics of patients.
We examined any association between respondents' attitudes toward or against anticoagulant therapy and responde nts' background characteristics by calculating ratios of proportion of respondents with a positive attitude toward anticoagulant therapy for each category of the characteristics.
We then examined an association between respondents' attitudes toward or against anticoagulant therapy and patient characteristics in the vignettes by building a logistic regression model adjusting all the characteristics of respondents.
No variable in the model was eliminated from the analysis. We used the generalized estimation equations approach (19, 20) to adjust for the influence of lack of independency of individual answers; as each respondent might answer the questions in the 8 vignettes consistently toward a specific choice, independence of individual answers was not guaranteed. Microsoft EXCEL2000 (Microsoft Corp.), and SAS System for Windows version 6.12 (SAS Institute Inc., Cary) were used in the analyses.
Results
We distributed the questionnaire to 209 physicians among 253 participants at the meeting, and obtained 139 responses (response rate of 67%). Thirteen responses were excluded because of incomplete answers and the remaining 126 responses were analyzed.
Most of the respondents were middle-aged male physicians (median age: 38 years old, the mean years since graduation from medical school: 14 years) ( Table 1 ). Twelve percent of them were cardiologists. The majority (72%) had their primary responsibility at teaching hospitals and about half (47%) at an academic setting.
For all the 8 vignettes presented, 26% of the respondents chose "warfarin" or "warfarin and aspirin" and 33% "aspirin" ( Table 2 ). Only 34% chose "warfarin" or "warfarin For editorial comment, see p 529. and aspirin" in one of the 4 vignettes of hypothetical patients without a risk for bleeding complication, showing positive attitude toward anticoagulant therapy in our current definition. For the vignettes of hypothetical patients with a risk for bleeding complication, more than 80% of respondents showed a negative attitude. Longer clinical experience and responsibility at a teaching hospital were negatively associated with the physicians' attitudes toward anticoagulant therapy, while experiences of preventive therapy for thromboembolism and a strong influence of clinical trials were positively associated with the therapy (Table 3) .
After adjusting all the physicians' background characteristics, respondents were shown to be about 70% less likely to prefer anticoagulant therapy when the patient was an octogenarian or when the patient had a risk for bleeding complication, although twice more likely to prefer the therapy when the patient had a risk for thromboembolism (Table 4 ).
Discussion
The respondents in this survey showed a very conservative attitude toward anticoagulant therapy in chronic AF pa- practice. This negative attitude toward anticoagulant therapy may be just a reflection of the preference for antiplatelet therapy. For 8 hypothetical patients, more respondents preferred antiplatelet therapy (i.e., "aspirin": 33%) than anticoagulant therapy (i.e., "warfarin and aspirin" or "warfarin": 25%). Previous surveys conducted in Japan already showed physicians' preference for antiplatelet therapy over anticoagulant therapy [the prescription rates in AF patients; warfarin: 14-17%, aspirin: 18-26%, ticlopidine: 8-26% (13, 14) ]. This could be due to the following reasons. First, antiplatelet therapy was also proved to decrease the incidence of thromboembolism (23) . Secondly, respondent physicians might have thought that antiplatelet therapy has a favorable risk-benefit ratio because of its low risk of major bleeding complications (24) .
Bungard et al proposed three factors to influence physicians in making a decision to prescribe anticoagulant therapy: physician-related factors, patient-related factors, and health care system-related factors (12) . Our survey revealed that several physician-related factors (years since graduation from medical school, major place of work, experiences of preventive therapy for thromboembolism due to AF, impact of clinical trials on own practice of anticoagulant prophylaxis) and patient-related factors (age, risks for thromboembolism and bleeding complication) were associated with respondent's preference of anticoagulant therapy. Of particular note is the finding that physicians with longer clinical experience or responsibility at teaching or academic settings were less likely to choose anticoagulant therapy. Since most of them were either generalists or subspecialists in the fields other than cardiology, they may not have the confidence to have updated knowledge about standard management of chronic AF. The number of such patients they see in their clinical fields may be too small to make them feel confident in the management of chronic AF.
The responders' negative attitude toward anticoagulant therapy in an octogenarian patient was very similar to the results reported by Beyth et al (22) . Surveys conducted in Western countries (25) (26) (27) (28) (29) (30) (31) (32) reported that elderly patients were less likely than middle-aged patients to be anticoagulated, in spite of the fact that aging is one of the most important risk factors for thromboembolisms in chronic AF patients (9) (10) (11) . Several explanations are possible for such hesitancy. First, respondent physicians might have a belief that elderly patients would have no significant gain of life in any case (33) . Second, they might have been afraid of a high bleeding complication rate in elderly patients as previously reported (34, 35) .
There are several limitations to this study. First, answers to the questions may not reflect actual practice. Since the questionnaire was self-administered, respondents might have given more idealistic answers than the reality. The questionnaire used in this survey might not have provided respondents with enough information to make the best decision, thus requiring some abstract judgements. Second, there might have been a sampling bias. The respondents in this survey were participants in the annual meeting of the Japanese Society of General Medicine, which consists of physicians who are knowledgeable about the standard practice in Western countries. The current results are thus likely to reflect a more positive attitude of physicians in Western countries. Therefore, the negative attitude shown here of Japanese physicians in this survey toward anticoagulant therapy is rather underestimated and should be a robust finding.
Conclusion
The Japanese physicians in this survey, especially those with longer clinical experiences or responsibility at a teaching hospital, have a negative attitude toward anticoagulant therapy in chronic AF patients. An advanced age and a risk of bleeding complications of patients are deterrent factors to the use of anticoagulant therapy. 
Scenarios
Note
Except for the described factors in each scenario, there are no other relevant factors which could affect your recommendation. For example, you can assume that blood pressure is normal and the patients are on no medication.
